Cardiology-CTVS Dialogues
Six common dietary supplements no better than placebo for reducing LDL cholesterol and CVD risk
Latest News and Guidelines
Olpasiran markedly reduces lipoprotein(a) in atherosclerotic cardiovascular disease: NEJM
Torsemide does not confer any survival benefit over Furosemide in HF: TRANSFORM HF trial
Pre-eclampsia closely associated with premature onset of obstructive coronary artery stenosis: BMJ
Vitamin D3 and Omega-3 supplementation fails to improve cardiac function: VITAL trial
Empagliflozin reduces risk of disease progression and death in high-risk CKD patients: NEJM
AI Improves accuracy of SPECT imaging for CAD
